United States In August 2003, the State of California outlawed the sale of penta- and octaBDE and products containing them, effective 1 January 2008. PBDEs are ubiquitous in the environment, and, according to the EPA, exposure may pose health risks. According to U.S. EPA's Integrated Risk Information System, evidence indicates that PBDEs may possess liver toxicity, thyroid toxicity, and neurodevelopmental toxicity. In June 2008, the U.S. EPA set a safe daily exposure level ranging from 0.1 to 7 μg/kg body weight per day for the four most common PBDE congeners. In April 2007, the legislature of the state of
Washington passed a bill banning the use of PBDEs. The State of
Maine Department of Environmental Protection has restrictions on PBDEs, and in 2008, the legislature passed a bill phasing out the use of decaBDE. The U.S. importers and manufacturers of PBDEs withdrew pentaBDE and octaBDE from sale in 2004, and decaBDE from sale by the end of 2013. In November 2024, the EPA added decaBDE to the
Toxic Substances Control Act to prohibit release into water during manufacturing, processing or distribution in commerce of decaBDE and decaBDE-containing products, and a phase-out of processing and distribution of wire and cable insulation containing decaDBE for nuclear power facilities.
Canada Since 2012, PBDEs are among chemicals prohibited from manufacture, use, sale, offer for sale or import, as regulated in the Prohibition of Certain Toxic Substances Regulations of the 1999 Canadian Environmental Protection Act. PBDEs are regarded in the regulation as "toxic to the environment and/or human health, are generally persistent, bioaccumulative, and/or inherently toxic." In 2017, it was decided to also list decaBDE. ==Alternatives==